Clinical Trial Update: MTX-001 for the Treatment of Non-Healing Venous Stasis Ulcers [Phase 2]

View source ↗

Summary

Merakris Therapeutics is conducting a Phase 2 trial of MTX-001 for non-healing venous stasis ulcers, including venous leg ulcers, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Leg Ulcer
• Venous Stasis Ulcer

Drugs mentioned

• MTX-001

Snippet

Sponsor: Merakris Therapeutics | Conditions: Venous Stasis Ulcer, Venous Leg Ulcer | Phase 2 | Status: RECRUITING